Celon Pharma S.A. Logo

Celon Pharma S.A.

ISIN: PLCLNPH00015 | Ticker: CLN | LEI: 259400Q0ERJT0NC5DT24

About Celon Pharma S.A.

Company Description

Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.

One huge advantage of Celon Pharma S.A. is its strong research and development facilities which allow us to create whole new classes of effective drugs. The research and development department in Celon Pharma S.A.employs over 160 scientists, of which one in four have PhD titles in molecular biology, pharmacy or chemistry.

We invest in the development of innovative pharmaceutical products which have the potential to treat cancers, neurological diseases, diabetes and other metabolic disorders. We have obtained financial resources for research into new drugs from the sale of generic drugs, as well as from the EU funds obtained under the Innovative Economy programme.

Year founded


Served area



Marymoncka 15, 05-152 Kazuń Nowy – Poland

Filings & Publications

Shareholder information

Shares outstanding



Dec. 1, 2016

Stock exchange(s)

Warsaw Stock Exchange



Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.